Human mitochondrial variants influence on oxygen consumption

Mitochondrion

Volumn 9, Issue 1, 2009, Pages 27-30

  Marcuello, Ana ^a   Martínez Redondo, Diana ^a,b   Dahmani, Yahya ^a   Casajús, José A ^a   Ruiz Pesini, Eduardo ^a,b,c   Montoya, Julio ^a,b   López Pérez, Manuel J ^a,b   Díez Sánchez, Carmen ^a,b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c FUNDACIÓN ARAID   (Spain)

Author keywords

J Mitochondrial haplogroup; Mitochondrial haplogroups; mtDNA variants; OXPHOS system; VO2max

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHOLESTEROL; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOCHONDRIAL DNA; OXYGEN; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; DNA EXTRACTION; EATING HABIT; EXERCISE; EXERCISE TEST; FITNESS; GENETIC VARIABILITY; HEART RATE; HUMAN; HUMAN CELL; LEBER HEREDITARY OPTIC NEUROPATHY; LIFESTYLE; LUNG GAS EXCHANGE; MALE; MITOCHONDRIAL ENERGY TRANSFER; MULTIPLE SCLEROSIS; NORMAL HUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SPAIN; SPIROMETRY; VOLUNTEER;

ADENOSINE TRIPHOSPHATE; ADULT; DNA; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; EXERCISE; EXERCISE TEST; HAPLOTYPES; HUMANS; MALE; MITOCHONDRIA; MITOCHONDRIA, MUSCLE; OXIDATIVE STRESS; OXYGEN CONSUMPTION;

EID: 60249093506     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2008.10.002     Document Type: Article

References (46)

1. Beckman K.B., and Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78 2 (1998) 547-581
2. Bouchard C., Daw E.W., et al. Familial resemblance for VO2max in the sedentary state: the HERITAGE family study. Med. Sci. Sports Exerc. 30 2 (1998) 252-258
3. Brown G.K. Bottlenecks and beyond: Mitochondrial DNA segregation in health and disease. J. Inherit. Metab. Dis. 20 1 (1997) 2-8
4. Brown M.D., Sun F., et al. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am. J. Hum. Genet. 60 2 (1997) 381-387
5. Brown M.D., Zhadanov S., et al. Novel mtDNA mutations and oxidative phosphorylation dysfunction in Russian LHON families. Hum. Genet. 109 1 (2001) 33-39
6. Cacabelos R., Fernandez-Novoa L., et al. Molecular genetics of Alzheimer's disease and aging. Methods Find. Exp. Clin. Pharmacol. 27 Suppl A (2005) 1-573
7. De Benedictis G., Rose G., et al. Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J. 13 12 (1999) 1532-1536
8. De Onis M., and Habicht J.-P. Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am. J. Clin. Nutr. 64 4 (1996) 650-658
9. DiMauro S., and Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 348 26 (2003) 2656-2668
10. Dionne F.T., Turcotte L., et al. Mitochondrial DNA sequence polymorphism, VO2max, and response to endurance training. Med. Sci. Sports Exerc. 23 2 (1991) 177-185
11. Durnin J.V., and Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br. J. Nutr. 32 1 (1974) 77-97
12. Finnila S., Lehtonen M.S., et al. Phylogenetic network for European mtDNA. Am. J. Hum. Genet. 68 6 (2001) 1475-1484
13. Ghafourifar P., Mousavizadeh K., et al. Mitochondria in multiple sclerosis. Front. Biosci. 13 (2008) 3116-3126
14. Hanefeld F.A., Ernst B.P., et al. Leber's hereditary optic neuropathy mitochondrial DNA mutations in childhood multiple sclerosis. Neuropediatrics 25 6 (1994) 331
15. Helgason A., Sigureth ardottir S., et al. mtDNA and the origin of the Icelanders deciphering signals of recent population history. Am. J. Hum. Genet. 66 3 (2000) 999-1016
16. Houshmand M., Sanati M.H., et al. Population screening for association of mitochondrial haplogroups BM, J, K and M with multiple sclerosis, interrelation between haplogroup J and MS in Persian patients. Mult. Scler. 11 6 (2005) 728-730
17. Howell N. LHON and other optic nerve atrophies, the mitochondrial connection. Dev. Ophthalmol. 37 (2003) 94-108
18. Ivanova R., Lepage V., et al. Mitochondrial genotype associated with French Caucasian centenarians. Gerontology 44 6 (1998) 349
19. Kalman B., and Alder H. Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis?. Acta Neurol. Scand. 98 4 (1998) 232-237
20. Kalman B., and Lublin F.D. The genetics of multiple sclerosis. A review. Biomed. Pharmacother. 53 8 (1999) 358-370
21. Kivisild T., Shen P., et al. The role of selection in the evolution of human mitochondrial genomes. Genetics 172 1 (2006) 373-387
22. Lesage R., Simoneau J.A., et al. Familial resemblance in maximal heart rate, blood lactate and aerobic power. Hum. Hered. 35 3 (1985) 182-189
23. Lev N., Ickowicz D., et al. Experimental encephalomyelitis induces changes in DJ-1, implications for oxidative stress in multiple sclerosis. Antioxid. Redox. Signal. 8 11-12 (2006) 1987-1995
24. Macaulay V., Richards M., et al. The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs. Am. J. Hum. Genet. 64 1 (1999) 232-249
25. Mirshafiey A., and Mohsenzadegan M. Antioxidant therapy in multiple sclerosis. Immunopharmacol. Immunotoxicol. (2008) 1-34
26. Montiel-Sosa F., Ruiz-Pesini E., et al. Differences of sperm motility in mitochondrial DNA haplogroup U sublineages. Gene 368 (2006) 21-27
27. Murakami H., Ota A., et al. Polymorphisms in control region of mtDNA relates to individual differences in endurance capacity or trainability. Jpn. J. Physiol. 52 3 (2002) 247-256
28. Niemi A.K., Hervonen A., et al. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum. Genet. 112 1 (2003) 29-33
29. Perusse L., Gagnon J., et al. Familial aggregation of submaximal aerobic performance in the HERITAGE Family study. Med. Sci. Sports Exerc. 33 4 (2001) 597-604
30. Richards M.B., Macaulay V.A., et al. Phylogeography of mitochondrial DNA in western Europe. Ann. Hum. Genet. 62 (1998) 241-260
31. Rivera M.A., Wolfarth B., et al. Three mitochondrial DNA restriction polymorphisms in elite endurance athletes and sedentary controls. Med. Sci. Sports Exerc. 30 5 (1998) 687-690
32. Rose G., Passarino G., et al. Paradoxes in longevity: sequence analysis of mtDNA haplogroup J in centenarians. Eur. J. Hum. Genet. 9 9 (2001) 701-707
33. Ross O.A., McCormack R., et al. Mitochondrial DNA polymorphism: its role in longevity of the Irish population. Exp. Gerontol. 36 7 (2001) 1161-1178
34. Ruiz-Pesini E., Lapena A.C., et al. Seminal quality correlates with mitochondrial functionality. Clin. Chim. Acta 300 1-2 (2000) 97-105
35. Ruiz-Pesini E., Lapena A.C., et al. Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am. J. Hum. Genet. 67 3 (2000) 682-696
36. Ruiz-Pesini E., Mishmar D., et al. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303 5655 (2004) 223-226
37. Sambrook J., Fristch E.F., et al. Molecular Cloning. A Laboratory Manual (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
38. Santoro A., Salvioli S., et al. Mitochondrial DNA involvement in human longevity. Biochim. Biophys. Acta 1757 9-10 (2006) 1388-1399
39. Schreibelt G., van Horssen J., et al. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res. Rev. 56 2 (2007) 322-330
40. Sidoti A., Antognelli C., et al. Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?. Mult. Scler. 13 4 (2007) 446-453
41. Siri W.E. Body composition from fluid spaces and density: analysis of methods 1961. Nutrition 9 5 (1993) 480-491 discussion 480, 492
42. Torroni A., Huoponen K., et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 144 4 (1996) 1835-1850
43. van der Walt J.M., Nicodemus K.K., et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72 4 (2003) 804-811
44. van Horssen J., Schreibelt G., et al. NAD(P)H: quinone oxidoreductase 1 expression in multiple sclerosis lesions. Free Radic. Biol. Med. 41 2 (2006) 311-317
45. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
46. Wong A., Cavelier L., et al. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum. Mol. Genet. 11 4 (2002) 431-438